| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/11/2001 | EP1114061A1 FACTOR VIIa INHIBITORS |
| 07/11/2001 | EP0876371B1 Reverse-turn mimetics and methods relating thereto |
| 07/11/2001 | CN1303381A Dipeptidyl peptidase IV effectors |
| 07/11/2001 | CN1303299A Method and compositions for peptide synthesis |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258947 Chemical intermediate for drugs |
| 07/10/2001 | US6258932 Tripeptide of defined amino acid sequence and having a c-terminal amide; viricides; treatment and prevention of human immunodeficiency virus |
| 07/10/2001 | US6258931 Synthesizing deoxyhypusine derivative by using ester of diprotected lysine, deblocking one nitrogen, condensing with 3-cyanopropanal, reducing to a triamine, protecting free amino groups, deblocking again, and acylating the free amino group |
| 07/10/2001 | US6258815 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 07/10/2001 | US6258782 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258572 Process for preparing L-aspartic acid |
| 07/10/2001 | CA2040947C Platelet-aggregation inhibitors |
| 07/10/2001 | CA1341270C Hypoglycaemic peptides |
| 07/05/2001 | WO2001047949A1 Aspartame derivative crystals |
| 07/05/2001 | WO2001047948A1 Novel dipeptide compound and medicinal use thereof |
| 07/05/2001 | WO2001047930A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | WO2001047901A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/05/2001 | WO2001047469A2 Treatment of ischemic brain injuries with brain targetted antioxidant compounds |
| 07/05/2001 | WO2000062620A3 Transformed cells useful for the control of pests |
| 07/05/2001 | US20010007037 Solid phase peptide synthesis; in situ generation of amino acid chloride by deblocking; coupling sterically hindered amino acid residues |
| 07/05/2001 | US20010007016 Analgesics, especially for cancer |
| 07/05/2001 | US20010007015 Can be used as the basic structures (template molecules) for inhibiting and analysing amyloid formation and cytotoxicity in amyloid illnesses |
| 07/05/2001 | CA2396533A1 Treatment of ischemic brain injuries with brain targetted antioxidant compounds |
| 07/05/2001 | CA2395948A1 Crystal of aspartame derivative |
| 07/05/2001 | CA2395275A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | CA2362849A1 Novel dipeptide compounds and their use as medicines |
| 07/04/2001 | EP1112284A1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 07/04/2001 | EP0773956B1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same |
| 07/04/2001 | EP0736038B1 Compounds with growth hormone releasing properties |
| 07/04/2001 | EP0634927B1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 07/03/2001 | US6255453 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/03/2001 | US6255344 Histidine derivatives, preparation, process, and their use as free antiradical agents |
| 07/03/2001 | US6255301 Amino acid derivatives and their use as thrombin inhibitors |
| 07/03/2001 | US6255286 Depsipeptides and drugs containing the same as the active ingredient |
| 07/03/2001 | US6255285 Phenethylamine derivatives |
| 07/03/2001 | US6255060 Method of detecting protein by immuno RNA |
| 06/28/2001 | WO2001046220A2 Bioactive oligopeptides |
| 06/28/2001 | WO2001046197A1 PEPTIDE β-TURN MIMETIC COMPOUNDS AND PROCESSES FOR MAKING THEM |
| 06/28/2001 | WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 06/28/2001 | WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | WO2001046125A2 Cd45 inhibitors |
| 06/28/2001 | WO2000063236A3 Adhesion modulatory peptides and methods for use |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | CA2393759A1 Peptide .beta.-turn mimetic compounds and processes for making them |
| 06/27/2001 | EP1110968A1 Thrombininhibitors as anticoagulant agents |
| 06/27/2001 | EP1110088A1 Energy transfer dyes |
| 06/27/2001 | EP1109928A1 Enzymatic oxidative deamination process |
| 06/27/2001 | EP1109826A1 Process for the preparation of neotame |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP0759066B1 Process for obtaining micro-organisms containing peptide amidase, micro-organisms obtained therewith, peptide amidases contained in them and use thereof |
| 06/27/2001 | CN1301173A Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 06/27/2001 | CN1301131A Dipeptide apoptosis inhibitors and the use thereof |
| 06/27/2001 | CN1067687C Polymorphic foams of growth hormone secretagogue |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252064 Process to prepare pharmaceutical compounds |
| 06/26/2001 | US6252041 Depsipeptides containing non-natural amino acids |
| 06/26/2001 | US6251939 Carbamate-based cationic lipids |
| 06/26/2001 | US6251902 Dipeptide derivatives as growth hormone secretagogues |
| 06/26/2001 | US6251864 Peptides and compounds that bind to a receptor |
| 06/26/2001 | US6251854 N-methyl-d-aspartate receptor channel blockers and method for identifying such |
| 06/26/2001 | US6251625 Enzymatic preparation of protected di- or oligopeptides and removal of the protective group used by splitting off |
| 06/23/2001 | CA2329487A1 Assay method |
| 06/21/2001 | WO2001044469A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
| 06/21/2001 | WO2001044214A1 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient |
| 06/21/2001 | WO2001010851B1 Process for the preparation of lysine-carboxyanhydride intermediates in the synthesis of lisinopril |
| 06/21/2001 | CA2394404A1 Process for producing kiss-1 peptide |
| 06/20/2001 | EP1107983A2 Benzodiazepine and benzothiazepine derivatives and hbsag peptides binding to annexins, their compositions and use |
| 06/20/2001 | EP1107980A1 CRYSTALLINE FORMS OF EtO 2?C-CH 2?-($i(R))Cgl-Aze-Pab-OH |
| 06/20/2001 | EP1107969A2 Collections of compounds |
| 06/20/2001 | EP0768308B1 derivatives of pyroglutaminic acid, preparation process and applications |
| 06/20/2001 | CN1300293A Process for the preparation of a tetrapeptide |
| 06/20/2001 | CN1300220A Peptide compositions and formulations and use of same |
| 06/19/2001 | US6248904 Phthalein dyes |
| 06/19/2001 | US6248903 Process for the preparation of methyl (2s)-2-[(3r)-3-(n-{tert-butyloxycarbonyl 9-amino)-2-oxopyrrolidin-1-yl]propionate |
| 06/19/2001 | US6248865 Compounds useful for the synthesis of dolastatin analogs |
| 06/19/2001 | US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/19/2001 | US6248717 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 06/19/2001 | US6248716 Prophylaxis or treatment of physical or mental stress-related disorders in an animal by administering an effective oligopeptide including tyrosine and phenylalanine units |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248543 Detecting microbiocides in sample; mix modulator and protein in sample and detect binding of modulator and protein |
| 06/19/2001 | US6248528 Drug screening by contacting test compound with human centrin protein and determining whether compound binds to protein |
| 06/19/2001 | US6248306 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 06/19/2001 | US6248304 Piperidine compound |
| 06/19/2001 | CA2137349C Peptide lung surfactants and therapeutic combinations |
| 06/19/2001 | CA2040180C Enzymatic process for the determination of beta-lactam antibiotics |
| 06/19/2001 | CA1341257C Benzhydrylamine derivatives |
| 06/14/2001 | WO2001042282A1 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/14/2001 | WO2001042225A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | WO2000068255A3 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 06/14/2001 | US20010003750 Used as research tools in pharmacological, diagnostic studies and treatment of diseases in mammals in which 1L-beta-protease activity is implicated; antiinflammatory agent |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/13/2001 | EP1106626A1 Process for the preparation of regular glycopeptides |
| 06/13/2001 | EP1106624A1 5-membered ring compounds |
| 06/13/2001 | EP1106606A2 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 06/13/2001 | EP1105422A1 Hepatitis c inhibitor peptides |
| 06/13/2001 | EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 06/13/2001 | EP1105415A1 Chemical synthesis of exochelins |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |